Close

innovationinstitute@childrensnational.org

Medical Devices to Address Youth Substance Use Disorders and Addiction

The Alliance for Pediatric Device Innovation (APDI) has opened a grant opportunity for pediatric medical devices that improve the monitoring, diagnosis or treatment of youth suffering from substance use disorder and addiction. Grants up to $50,000 each are available for pediatric-specific solutions selected by a panel of experts from submitted proposals. Up to $150,000 in grant funds are available for distribution through this program.

The National Institutes of Health (NIH) reports that over 3.6 million U.S. youth, ages 12 to 17, used illicit drugs in 2022. In that same period, an average of 22 youth, ages 12 to 18, died weekly from an overdose. Often, these adolescents did not show the expected warning signs before an overdose, such as problems with alcohol, drugs or prior substance use treatment. Of the teens and tweens who fatally overdosed, only 1 in 10 had a history of treatment for a substance use problem, and only 1 in 7 had ever experienced a prior nonfatal overdose.

Read More

Five finalists announced in Alliance for Pediatric Device Innovation’s “Make Your Medical Device Pitch For Kids!”™ competition in collaboration with MedTech Color

WASHINGTON (January 8, 2023) – Alliance for Pediatric Device Innovation (APDI), the federally funded consortium led by Children’s National Hospital, announces the finalists of its special MedTech Color edition of “Make Your Medical Device Pitch for Kids!”™ competition. This edition supports pediatric medical device advancements from African American and Hispanic innovators.

The competition aims to advance devices that meet critical patient needs while promoting a more inclusive approach to medical technology innovation. The finalists will compete for a share of up to $50,000 in grants funded by the Food and Drug Administration (FDA) that will support innovators’ efforts to bring their devices to the commercial market for the benefit of children everywhere

Read More

FDA awards nearly $7.5 million to pediatric device consortium led by Children’s National Hospital

WASHINGTON, D.C., Sept. 19, 2023 (GLOBE NEWSWIRE) — To foster the development and commercialization of medical devices designed for children, the Food and Drug Administration (FDA) has awarded a nearly $7.5 million grant to the Alliance for Pediatric Device Innovation (APDI), a consortium led by Children’s National Hospital.

Read More

FDA awards nearly $7.5 million to pediatric device consortium led by Children’s National Hospital

WASHINGTON, D.C., Sept. 19, 2023 (GLOBE NEWSWIRE) — To foster the development and commercialization of medical devices designed for children, the Food and Drug Administration (FDA) has awarded a nearly $7.5 million grant to the Alliance for Pediatric Device Innovation (APDI), a consortium led by Children’s National Hospital. The nonprofit group, which is one of five in the FDA’s Pediatric Device Consortia (PDC) program, will utilize the five-year grant to provide a platform of services, expertise and funding that supports pediatric innovators in bringing medical devices to the market that specifically address the needs of children. New in this cycle, APDI will provide expertise on evidence generation, including the use of real-world evidence (RWE), for pediatric device development.

Read More

Make Your Medical Device Pitch for Kids! ™ – Joint NCC-PDI + CTIP Edition

Under this solicitation, two FDA-funded Pediatric Device Consortia grant programs, CTIP and NCC-PDI, have come together to maximize their resources to select and support a new cohort of device innovators to receive grant funding and wraparound services by the two consortia. We are seeking proposals from inventors from all sectors – including the business community and academic medical centers – who are proposing a medical device solution to address a significant unmet need in the pediatric population.

Proposals should be directed towards the development of a commercializable product, and not research of a scientific concept. Issues such as prototyping, manufacturing, marketing, and regulatory clearance will be paramount and should be addressed explicitly.

Read More

IllumiCare App Recommends Trials as Therapeutic Option, New Data Capture Interface Increases Real-World Patient Compliance, More

December 27, 2022 | A 16-gene molecular signature investigation based on gene expression differences between patients with and without local recurrence after breast-conserving surgery; analytically sensitive infectious disease panels to support laboratory research; eClinical solutions to make clinical

Read More